Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherLiab,goodWill,otherAssets,cash,totalCurrentLiabilities,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,otherCurrentAssets,intangibleAssets,capitalSurplus,retainedEarnings,treasuryStock,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,investments,netBorrowings,issuanceOfStock,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Aug 12, 2021) 4","Short Ratio (Aug 12, 2021) 4","Short % of Float (Aug 12, 2021) 4","Short % of Shares Outstanding (Aug 12, 2021) 4","Shares Short (prior month Jul 14, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry,address2
t0,EDAP,45779000.0,33346100,925000,,-366000,,-424000,3718000,4216000,-427000,-427000,,-20000,,,,58000,10350000,10777000,6134000,61000,,-424000,-424000,26431000.0,48191000.0,4604000.0,74622000.0,48191000.0,4453000.0,2412000.0,1703000.0,44961000.0,15348000.0,5135000.0,65372000.0,11183000.0,5215000.0,8610000.0,9297000.0,,,,,,,,,0.0,-350000.0,21598000.0,-1124000.0,20580000.0,70000.0,-738000.0,21598000.0,809000.0,-350000.0,,,,,,,,50024000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,5.9148,1630507285,-0.105199814,6.02,6.03,5.9,19769,USD,NGM,197235520,-14400000,False,False,REGULAR,2,-1.7475052,5.9 - 6.03,us_market,0,EDAP TMS S.A.,6.02,5.9,5.94,8,14,finmb_27892,NasdaqGM,EDAP TMS S.A.,EUR,78793,94333,2.2648,0.6204932,3.65 - 10.68,-4.7652,-0.44617978,3.65,10.68,1620763200,1637060340,1637582400,454.98462,0.013,0.22,0.05,118.296005,0.92,5.9819446,-0.067144394,-0.011224509,7.2315216,-1.3167214,-0.18208084,26.885456,6.4291306,15,America/New_York,EDT,1.74,,,10.68,3.65,5.98,7.23,78.79k,94.33k,33.35M,,29.73M,0.00%,32.45%,64.18k,0.77,,0.19%,151.95k,,,,,,0.00%,,,,,"Dec 30, 2020","Jun 29, 2021",0.28%,3.83%,,,45.45M,1.52,11.80%,18.38M,3.96M,129k,0.01,,44.96M,1.39,8.08M,16.76,4.26,0.92,,,Value,69120,Healthcare,223,"EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",Lyon,33 4 72 15 31 50,France,http://www.edap-tms.com,86400,Parc dâActivites la Poudrette-Lamartine,33 4 72 15 31 51,Medical Devices,"4/6, rue du DauphinÃ© Vaulx-en-Velin"
t-1,EDAP,24444000.0,33346100,851000,,892000,,773000,3281000,4370000,238000,238000,,-20000,,,,119000,10302000,10064000,5932000,654000,,773000,773000,26443000.0,26856000.0,8503000.0,53299000.0,26856000.0,4339000.0,2412000.0,1760000.0,24382000.0,19268000.0,5570000.0,43557000.0,10264000.0,1157000.0,8348000.0,9374000.0,-1000.0,,,,,,,,0.0,-294000.0,-1230000.0,539000.0,-314000.0,-269000.0,1479000.0,-1230000.0,167000.0,-294000.0,,,,,,,,24289000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,5.9148,1630507285,-0.105199814,6.02,6.03,5.9,19769,USD,NGM,197235520,-14400000,False,False,REGULAR,2,-1.7475052,5.9 - 6.03,us_market,0,EDAP TMS S.A.,6.02,5.9,5.94,8,14,finmb_27892,NasdaqGM,EDAP TMS S.A.,EUR,78793,94333,2.2648,0.6204932,3.65 - 10.68,-4.7652,-0.44617978,3.65,10.68,1620763200,1637060340,1637582400,454.98462,0.013,0.22,0.05,118.296005,0.92,5.9819446,-0.067144394,-0.011224509,7.2315216,-1.3167214,-0.18208084,26.885456,6.4291306,15,America/New_York,EDT,1.74,,,10.68,3.65,5.98,7.23,78.79k,94.33k,33.35M,,29.73M,0.00%,32.45%,64.18k,0.77,,0.19%,151.95k,,,,,,0.00%,,,,,"Dec 30, 2020","Jun 29, 2021",0.28%,3.83%,,,45.45M,1.52,11.80%,18.38M,3.96M,129k,0.01,,44.96M,1.39,8.08M,16.76,4.26,0.92,,,Value,69120,Healthcare,223,"EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",Lyon,33 4 72 15 31 50,France,http://www.edap-tms.com,86400,Parc dâActivites la Poudrette-Lamartine,33 4 72 15 31 51,Medical Devices,"4/6, rue du DauphinÃ© Vaulx-en-Velin"
t-2,EDAP,23075000.0,33346100,938000,,945000,,780000,3871000,7028000,2219000,2219000,,-57000,,,,165000,15364000,13145000,8336000,-1274000,,780000,780000,28945000.0,26248000.0,3643000.0,55193000.0,3830000.0,4646000.0,2412000.0,1028000.0,24696000.0,21502000.0,5599000.0,45393000.0,12338000.0,1143000.0,7989000.0,5708000.0,1000.0,761000.0,66548000.0,-40139000.0,-3991000.0,374000.0,4532000.0,-3063000.0,-422000.0,1205000.0,953000.0,1465000.0,6475000.0,330000.0,3985000.0,-2248000.0,-526000.0,-362000.0,1706000.0,3141000.0,60000.0,2105000.0,-36000.0,-554000.0,1137000.0,23891000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,5.9148,1630507285,-0.105199814,6.02,6.03,5.9,19769,USD,NGM,197235520,-14400000,False,False,REGULAR,2,-1.7475052,5.9 - 6.03,us_market,0,EDAP TMS S.A.,6.02,5.9,5.94,8,14,finmb_27892,NasdaqGM,EDAP TMS S.A.,EUR,78793,94333,2.2648,0.6204932,3.65 - 10.68,-4.7652,-0.44617978,3.65,10.68,1620763200,1637060340,1637582400,454.98462,0.013,0.22,0.05,118.296005,0.92,5.9819446,-0.067144394,-0.011224509,7.2315216,-1.3167214,-0.18208084,26.885456,6.4291306,15,America/New_York,EDT,1.74,,,10.68,3.65,5.98,7.23,78.79k,94.33k,33.35M,,29.73M,0.00%,32.45%,64.18k,0.77,,0.19%,151.95k,,,,,,0.00%,,,,,"Dec 30, 2020","Jun 29, 2021",0.28%,3.83%,,,45.45M,1.52,11.80%,18.38M,3.96M,129k,0.01,,44.96M,1.39,8.08M,16.76,4.26,0.92,,,Value,69120,Healthcare,223,"EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",Lyon,33 4 72 15 31 50,France,http://www.edap-tms.com,86400,Parc dâActivites la Poudrette-Lamartine,33 4 72 15 31 51,Medical Devices,"4/6, rue du DauphinÃ© Vaulx-en-Velin"
t-3,EDAP,22734000.0,33346100,1090000,,-879000,,-1001000,3167000,3964000,-293000,-293000,,-12000,,,,122000,9433000,9726000,5469000,-586000,,-1001000,-1001000,26493000.0,25146000.0,8521000.0,51639000.0,25146000.0,4448000.0,2412000.0,1739000.0,19929000.0,19102000.0,5928000.0,41560000.0,11572000.0,1219000.0,9455000.0,9122000.0,,,,,,,,,0.0,1205000.0,953000.0,1465000.0,6475000.0,330000.0,3985000.0,-2248000.0,-526000.0,-362000.0,1706000.0,3141000.0,60000.0,2105000.0,-36000.0,-554000.0,1137000.0,22458000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,5.9148,1630507285,-0.105199814,6.02,6.03,5.9,19769,USD,NGM,197235520,-14400000,False,False,REGULAR,2,-1.7475052,5.9 - 6.03,us_market,0,EDAP TMS S.A.,6.02,5.9,5.94,8,14,finmb_27892,NasdaqGM,EDAP TMS S.A.,EUR,78793,94333,2.2648,0.6204932,3.65 - 10.68,-4.7652,-0.44617978,3.65,10.68,1620763200,1637060340,1637582400,454.98462,0.013,0.22,0.05,118.296005,0.92,5.9819446,-0.067144394,-0.011224509,7.2315216,-1.3167214,-0.18208084,26.885456,6.4291306,15,America/New_York,EDT,1.74,,,10.68,3.65,5.98,7.23,78.79k,94.33k,33.35M,,29.73M,0.00%,32.45%,64.18k,0.77,,0.19%,151.95k,,,,,,0.00%,,,,,"Dec 30, 2020","Jun 29, 2021",0.28%,3.83%,,,45.45M,1.52,11.80%,18.38M,3.96M,129k,0.01,,44.96M,1.39,8.08M,16.76,4.26,0.92,,,Value,69120,Healthcare,223,"EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer. It also provides disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology. This segment offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.",Lyon,33 4 72 15 31 50,France,http://www.edap-tms.com,86400,Parc dâActivites la Poudrette-Lamartine,33 4 72 15 31 51,Medical Devices,"4/6, rue du DauphinÃ© Vaulx-en-Velin"
